NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome: To date, 41 patients harboring a pathogenic alteration (i.e., a single nucleotide variant or a deletion in NR2F1 locus) have been described, all associated to the BBSOAS (Table 1).